CTOs on the Move

Hikma Pharmaceuticals

www.hikma.com

 
At Hikma we put better health within reach, every day. We create high quality medicines, and we make them accessible and affordable to the people who need them.
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million
  • www.hikma.com
  • 246 Industrial Way West
    Eatontown, NJ USA 07724
  • Phone: 800.631.2174

Executives

Name Title Contact Details
Aaron Schaub
US Head of Information Security Information Security Profile

Similar Companies

Envision Pharma Group

Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications, and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions.

Genvion Corporation

Genvion Corporation is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neurana Pharmaceuticals

Neurana Pharmaceuticals is a privately held clinical stage San Diego based specialty pharmaceutical company developing a novel treatment for acute muscle spasms. The Company was founded in 2013 by veteran biotech entrepreneurs David F. Hale and Jeffrey Raser to focus on central nervous system (CNS) diseases and disorders.

Star Medical RX (A Division of Apria Healthcare)

Star Medical RX (A Division of Apria Healthcare) is a Riverside, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedPharm

MedPharm is a world-leading contract provider of topical and transdermal product design and development services. Our delivery of robust and innovative research has commanded recognition from regulators and investors alike. We utilise our unique cost-effective performance testing models to mitigate risk and accelerate development times.